Brief: Initiator Pharma Reports Positive Results From Toxicology Study
Dec 15 (Reuters) - Initiator Pharma A/S INIT.TE :
* INITIATOR PHARMA REPORTS POSITIVE RESULTS FROM THE 28 DAYS
TOXICOLOGY STUDY IN MINI-PIGS FOR ITS LEAD DRUG CANDIDATE
IPED2015
* AIM OF INITIATING A PHASE 1 CLINICAL TRIAL NEXT YEAR.
Source text for Eikon: ID:nWkr7FGdqZ
Further company coverage: INIT.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD